Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes

Part of paid clinical trials in Iowa City, Iowa.

Sponsor
Anna Stanhewicz, PhD
Study ID
NCT05946785
Phase
EARLY_PHASE1
Status
Recruiting
Apply to this trial

Conditions

  • Gestational Diabetes
  • Vascular Endothelial Function

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 50 Years
Healthy Volunteers
Accepted

Interventions

  • Acetylcholine — DRUG
    acetylcholine is perfused at 10 ascending concentrations (10\^-10M - 10\^-1 M) for 5 minutes each
  • insulin aspart — DRUG
    insulin aspart is perfused at 5 ascending concentrations (10\^-8M - 10\^-4 M) for 10 minutes each

Study Details

The purpose of this investigation is to examine the role of oxidative stress in aberrant microvascular function in otherwise healthy women with a history of GDM.

Key Dates

Start date
Jul 1, 2023
Status verified
May 2025
Primary completion
Dec 31, 2026
Completion
Jun 1, 2027

Study Design

Enrollment
28 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE

Arms

  • Placebo Comparator: local lactated Ringer's perfusion
    lactated Ringer's is perfused through the microdialysis fiber to serve as the vehicle control
  • Experimental: local ascorbate perfusion
    local ascorbate is perfused through the microdialysis fiber to serve as the antioxidant experimental treatment
  • Experimental: local L-NAME perfusion
    local L-NAME is perfused through the microdialysis fiber to inhibit nitric oxide synthase

Primary Outcome Measure

microvascular acetylcholine-mediated dilation [ Time Frame: at the study visit, an average of 4 hours ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of IowaIowa CityIowa52242
Anna Stanhewicz, PhD
[email protected]
319-467-1732

Find similar trials in Iowa City, IA

By research site
University of Iowa· Iowa City, IA

Related Studies